Articles Companion animals

26 August 2026

Characterization and outcomes of cats with cardiomyopathy undergoing subcutaneous ureteral bypass device placement.

Clinical evidence update from Journal of veterinary internal medicine

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of veterinary internal medicine in 2026 evaluated characterization and outcomes of cats with cardiomyopathy undergoing subcutaneous ureteral bypass device placement..

Key Findings

Limited data exist on the characterization and outcomes of cats with cardiomyopathy and benign ureteral obstruction treated by subcutaneous ureteral bypass (SUB) placement. Characterize cardiomyopathies, assess perioperative and long-term outcomes, and determine if an association exists between left atrial size and fluid overload (FO) or survival. Ninety-four cats presented for SUB placement between 2010 and 2022 at the Veterinary Teaching Hospital of the University of Montreal. Retrospective review of medical records including physical examination, serum creatinine concentration, echocardiography, and outcome. Cats were grouped as:...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Core decompression augmented with bone marrow aspirate concentrate for refractory distal sesamoid bone pathology in horses A retrospective clinical study.

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Characterization and outcomes of cats with cardiomyopathy undergoing subcutaneous ureteral bypass device placement.

Clinical evidence update from Journal of veterinary internal medicine

Comments

List

Add

Tag

Related Articles

20 August 2026
Circulating renin-angiotensin-aldosterone system markers in cats with non-hypertensive chronic kidney disease or systemic arterial hypertension.

Circulating renin-angiotensin-aldosterone system markers in cats with non-hypertensive chronic kidney disease or systemic arterial hypertension.

20 August 2026
Long-Term Follow-Up After Acute Gastroenteritis Caused by Giardia Infection in Juvenile Dogs.

Long-Term Follow-Up After Acute Gastroenteritis Caused by Giardia Infection in Juvenile Dogs.

20 August 2026
Prevalence and radiographic features of cyst-like lesions in German Warmblood horses presented for pre-purchase examination.

Prevalence and radiographic features of cyst-like lesions in German Warmblood horses presented for pre-purchase examination.

19 August 2026
Clinically important abnormalities are common in senior cats perceived to be healthy by owners.

Clinically important abnormalities are common in senior cats perceived to be healthy by owners.

19 August 2026
Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5-47 Months A Retrospective Case Series.

Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5-47 Months A Retrospective Case Series.

More news

All A-Buzz in Amherst, Massachusetts

Dechra to Establish Global Headquarters in Boston keyboard_arrow_down

EXPRESS Longitudinal evaluation of discordant symmetric dimethylarginine and creatinine as markers of glomerular filtration rate in radioiodine-treated hyperthyroid cats.

A Multicenter Observational Study Comparing Survival of Pugs and Dogs of Other Breeds With Protein-Losing Enteropathy.

Prevalence of abortion and stillbirth in dairy cows in Ethiopia a systematic review and meta-analysis.

Newsletter